Bimekizumab, CAS [[1418205-77-2]]

Produktübersicht

• Artikelname: Bimekizumab, CAS [[1418205-77-2]]
• Artikelnummer: MCE-HY-P99280
• Hersteller Artikelnummer: HY-P99280
• Alternativnummer: MCE-HY-P99280-5MG,MCE-HY-P99280-1MG,MCE-HY-P99280-10MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: Anti-Human IL17A/IL-17F Recombinant Antibody, CDP4940, UCB-4940

Produktbeschreibung

Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanised monoclonal antibody, can selectively neutralises IL-17A and IL-17F. Both of them are pro-osteogenic with respect to human periosteum-derived cell (hPDC) differentiation. Thus Bimekizumab blocks the inflammation-driven osteogenic differentiation[1].

Produkteigenschaften

• Molekulargewicht: (147.24 kDa)
• Reinheit: 99.52
• CAS Nummer: [1418205-77-2]
• Target-Kategorie: Interleukin Related

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies